Salvage induction chemotherapy after azacitdine treatment failure in patients who received azacitidine as a bridge to allogeneic stem cell transplantation

Br J Haematol. 2014 Jul;166(2):303-6. doi: 10.1111/bjh.12844. Epub 2014 Mar 21.

Authors

Karen W L Yee¹, Joseph Brandwein, Aaron D Schimmer, Vikas Gupta, Ryan Del Bel, Wei Xu, Mark D Minden, Andre C Schuh

Affiliation

¹ Division Medical Oncology & Haematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada. karen.yee@uhn.ca.

PMID: 24650042
DOI: 10.1111/bjh.12844

No abstract available

Keywords: acute myeloid leukaemia; allogeneic stem cell transplantation; azacitidine failure; induction chemotherapy; myelodysplastic syndrome.

Publication types

Letter

MeSH terms

Adult
Aged
Antimetabolites, Antineoplastic / therapeutic use*
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Azacitidine / therapeutic use*
Drug Evaluation / methods
Female
Hematopoietic Stem Cell Transplantation
Humans
Induction Chemotherapy / methods
Kaplan-Meier Estimate
Leukemia / drug therapy*
Male
Middle Aged
Myelodysplastic Syndromes / drug therapy*
Retrospective Studies
Salvage Therapy / methods*
Treatment Failure
Young Adult

Substances

Antimetabolites, Antineoplastic
Azacitidine